COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00984841
Recruitment Status : Completed
First Posted : September 25, 2009
Last Update Posted : September 25, 2009
Information provided by:
Scranton-Temple Residency Program

Brief Summary:
The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

Condition or disease Intervention/treatment Phase
Diabetes Mellitus Other: Tailored letter Not Applicable

Detailed Description:

Diabetes care in the US is less than optimal. Some authors have found that targeted patient letters are also an effective tool to improve outcomes when they are part of a comprehensive disease management plan. Local patient satisfaction surveys had revealed that many patients had sub‐optimal understanding of diabetes measures and of the importance of controlling these measures to reduce diabetic complications. We wondered if tailored patient letters and enclosed lab orders when due might increase patient awareness of diabetes measures and increase patient engagement.We hypothesized that the addition of targeted patient letters with enclosed lab orders to an ongoing performance improvement program would further improve diabetes care.

We conducted a randomized controlled study of tailored patient letters and diabetes lab orders at our two resident‐based clinics.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 467 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?"
Study Start Date : January 2009
Actual Primary Completion Date : April 2009
Actual Study Completion Date : July 2009

Arm Intervention/treatment
Experimental: Tailored letter
Patients in the tailored letter group received by mail a tailored letter detailing their diabetes measures, together with enclosed orders for lab tests when due, and reminder of or scheduling for an office appointment.
Other: Tailored letter
Active Comparator: Usual Care
Patients in the usual care group were part of a practice wide quality improvement process.
Other: Tailored letter

Primary Outcome Measures :
  1. Diabetes summary quality measure [ Time Frame: 4 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All active patients age 18 to 75 years with a diagnosis of diabetes mellitus were eligible.
  • An active patient was defined as one having an ICD‐9 code on the active problem list identifying the patient as diabetic, and a progress note in the EMR associated with an office visit within the prior 12 months.

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00984841

Layout table for location information
United States, Pennsylvania
Scranton-Temple Health Center
Scranton, Pennsylvania, United States, 18510
Sponsors and Collaborators
Scranton-Temple Residency Program
Layout table for investigator information
Principal Investigator: John R Guzek, MD Scranton-Temple Residency Program
Layout table for additonal information
Responsible Party: John R Guzek, MD, Scranton-Temple Residency Program Identifier: NCT00984841    
Other Study ID Numbers: STRP001
First Posted: September 25, 2009    Key Record Dates
Last Update Posted: September 25, 2009
Last Verified: September 2009
Keywords provided by Scranton-Temple Residency Program:
Diabetes Mellitus targeted mailing
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases